Senior Principal Scientist Pharmacology
Il y a 3 jours
Beerse, Flanders, Belgique
Johnson & Johnson Co.
Temps plein
Gratuit avec email ou Google
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
Gratuit avec email ou Google
En continuant, vous acceptez nos Conditions d’utilisation & Politique de confidentialité.
pAt Johnson Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com. /p pAs guided by Our Credo, Johnson Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson Johnson, we respect the diversity and dignity of our employees and recognize their merit. /p pPlease note that this role is available across multiple countries and may be posted under different requisition numbers to comply with local requirements. While you are welcome to apply to any or all of the postings, we recommend focusing on the specific country(s) that align with your preferred location(s): /p pBelgium R
- , United States of America R
- /p pRemember, whether you apply to one or all of these requisition numbers, your applications will be considered as a single submission. /p h3Job Function: /h3 pDiscovery Pre-Clinical/Clinical Development /p h3Job Sub Function: /h3 pPharmacology /p h3Job Category: /h3 pScientific/Technology /p h3All Job Posting Locations: /h3 pBeerse, Antwerp, Belgium /p h3Job Description: /h3 h3Position Title /h3 pSenior Principal Scientist Pharmacology /p p3Rs Portfolio Innovation and External Engagement /p br/ h3Location /h3 pBeerse, Belgium or Spring House, US. /p h3Role Summary /h3 pThe Sr. Principal Scientist SIS Scientific Lead is a senior scientific role within Scientific In Vivo Strategies (SIS), responsible for driving the identification and enablement of 3Rs innovation opportunities into the discovery and preclinical portfolio, including new approach methodologies (NAMs). /p pOperating within the enterprise 3Rs framework and aligned with Discovery, Product Development Supply (DPDS), PSTS (Preclinical Safety and Translational Sciences), and SIS strategic priorities, this role brings deep NAMs expertise (i.e., refined in vivo, ex vivo, complex in vitro models (CIVMs)/microphysiological systems (MPS)/organoids, and/or in silico approaches) to enable portfolio-relevant 3Rs innovation that strengthens discovery and preclinical assessment and improves preclinical-to-clinical translatability while advancing 3Rs objectives. The individual will serve as a NAMs subject‑matter expert for SIS, DPDS, and Therapeutic Area stakeholders, ensuring that both internal and external NAM opportunities are identified and evaluated through portfolio-relevant, translational, and regulatory-aligned perspectives. /p h3Primary
Responsibilities:
/h3 h3NAMs Scientific Engagement and Portfolio Integration: /h3 ul liEngage with fellow SIS Scientific Leads and stakeholders to identify and evaluate ex vivo, in vitro, and in silico (in partnership with data science colleagues) NAM opportunities relevant to discovery and development programs /li liProvide subject‑matter expert‑level guidance on applicability, strengths, limitations and readiness of NAMs within specific disease, modality and contexts of use /li liDrive relevant incorporation of NAMs into program strategies, ensuring alignment with portfolio goals, scientific rigor and the broader enterprise 3Rs innovation framework /li /ul h3External NAMs Landscape and Regulatory Awareness: /h3 ul liMaintain active awareness of the external NAMs landscape, including academic advances, emerging platforms and biotech innovations /li liEvaluate external NAM developments in the context of scientific maturity, translational relevance, and evolving global regulatory perspectives (e.g., FDA, EMA, ICH, etc.) /li liTranslate external and regulatory signals into clear, balanced scientific insights to inform on current NAMs integration opportunities as well as to anticipate future state /li /ul h3Internal Capability Enablement: /h3 ul liLiaison with fellow SIS Scientific Leads as well as internal functional and therapeutic area teams to assess existing NAM capabilities and gaps, relative to portfolio needs and regulatory expectations /li liInform prioritization of NAM development/evaluation and validation efforts based on scientific value‑add, feasibility and anticipated regulatory acceptance /li liSupport development of internal guidance to enable confident and consistent application of NAMs /li /ul h3Scientific Collaboration and Communication: /h3 ul liServe as a scientific thought partner to drive project teams to consider 3Rs innovation/NAM‑enabled approaches /li liContribute to internal scientific reviews, forums and working groups focused on 3Rs/NAMs innovation /li liSupport external scientific publications, presentations and internal
- , United States of America R
- /p pRemember, whether you apply to one or all of these requisition numbers, your applications will be considered as a single submission. /p h3Job Function: /h3 pDiscovery Pre-Clinical/Clinical Development /p h3Job Sub Function: /h3 pPharmacology /p h3Job Category: /h3 pScientific/Technology /p h3All Job Posting Locations: /h3 pBeerse, Antwerp, Belgium /p h3Job Description: /h3 h3Position Title /h3 pSenior Principal Scientist Pharmacology /p p3Rs Portfolio Innovation and External Engagement /p br/ h3Location /h3 pBeerse, Belgium or Spring House, US. /p h3Role Summary /h3 pThe Sr. Principal Scientist SIS Scientific Lead is a senior scientific role within Scientific In Vivo Strategies (SIS), responsible for driving the identification and enablement of 3Rs innovation opportunities into the discovery and preclinical portfolio, including new approach methodologies (NAMs). /p pOperating within the enterprise 3Rs framework and aligned with Discovery, Product Development Supply (DPDS), PSTS (Preclinical Safety and Translational Sciences), and SIS strategic priorities, this role brings deep NAMs expertise (i.e., refined in vivo, ex vivo, complex in vitro models (CIVMs)/microphysiological systems (MPS)/organoids, and/or in silico approaches) to enable portfolio-relevant 3Rs innovation that strengthens discovery and preclinical assessment and improves preclinical-to-clinical translatability while advancing 3Rs objectives. The individual will serve as a NAMs subject‑matter expert for SIS, DPDS, and Therapeutic Area stakeholders, ensuring that both internal and external NAM opportunities are identified and evaluated through portfolio-relevant, translational, and regulatory-aligned perspectives. /p h3Primary
Responsibilities:
/h3 h3NAMs Scientific Engagement and Portfolio Integration: /h3 ul liEngage with fellow SIS Scientific Leads and stakeholders to identify and evaluate ex vivo, in vitro, and in silico (in partnership with data science colleagues) NAM opportunities relevant to discovery and development programs /li liProvide subject‑matter expert‑level guidance on applicability, strengths, limitations and readiness of NAMs within specific disease, modality and contexts of use /li liDrive relevant incorporation of NAMs into program strategies, ensuring alignment with portfolio goals, scientific rigor and the broader enterprise 3Rs innovation framework /li /ul h3External NAMs Landscape and Regulatory Awareness: /h3 ul liMaintain active awareness of the external NAMs landscape, including academic advances, emerging platforms and biotech innovations /li liEvaluate external NAM developments in the context of scientific maturity, translational relevance, and evolving global regulatory perspectives (e.g., FDA, EMA, ICH, etc.) /li liTranslate external and regulatory signals into clear, balanced scientific insights to inform on current NAMs integration opportunities as well as to anticipate future state /li /ul h3Internal Capability Enablement: /h3 ul liLiaison with fellow SIS Scientific Leads as well as internal functional and therapeutic area teams to assess existing NAM capabilities and gaps, relative to portfolio needs and regulatory expectations /li liInform prioritization of NAM development/evaluation and validation efforts based on scientific value‑add, feasibility and anticipated regulatory acceptance /li liSupport development of internal guidance to enable confident and consistent application of NAMs /li /ul h3Scientific Collaboration and Communication: /h3 ul liServe as a scientific thought partner to drive project teams to consider 3Rs innovation/NAM‑enabled approaches /li liContribute to internal scientific reviews, forums and working groups focused on 3Rs/NAMs innovation /li liSupport external scientific publications, presentations and internal